1 asset in Mitochondrial Neurogastrointestinal Encephalomyopathy

Therapeutic assets addressing Mitochondrial Neurogastrointestinal Encephalomyopathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D Mitochondrial Neurogastrointestinal Encephalomyopathy	Masonic Cancer Center, University of Minnesota	P2	CCC (53)